24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Evolutionary and population genetics, and Genetic epidemiology<br />

predisposition to lymphoid tumors. Most <strong>of</strong> the NBS patients are <strong>of</strong><br />

Slavic origin and carried a major founder mutation 657del5 <strong>of</strong> the NBN<br />

gene. The prevalence <strong>of</strong> the 657del5 in the West Ukraine was previously<br />

studied by R. Varon et al. (2000) and frequency <strong>of</strong> heterozygotes<br />

was estimated as 1:182, expected NBS cases - 1:133 000. Since 1999<br />

and till <strong>2009</strong> the 30 NBS cases were diagnosed in Ukraine, half <strong>of</strong><br />

them - in the Lviv region <strong>of</strong> the West Ukraine. The purpose <strong>of</strong> this study<br />

was to evaluate the prevalence <strong>of</strong> 657del5 mutation <strong>of</strong> the NBN gene<br />

in Lviv population upon a base <strong>of</strong> verified NBS cases. The total number<br />

<strong>of</strong> 511598 children were born in Lviv region in 1989-2007 years and<br />

11-years period was marked by NBS case appearance: 1989 (1), 1990<br />

(1), 1992 (2), 1994 (1), 1998 (2), 2001 (1), 2002 (1), 2003 (2), 2004<br />

(1), 2005 (1), 2007 (2). Thus, in the time span <strong>of</strong> 2 years, 1-2 new NBS<br />

cases are expected to be born. The frequency <strong>of</strong> Nijmegen breakage<br />

syndrome in Lviv population is estimated as 1 per 13640-34106 neonates,<br />

whereas the prevalence <strong>of</strong> 657del5 heterozygotes is approximately<br />

1 per 58-95 neonates. The high frequency <strong>of</strong> heterozygous<br />

carriers <strong>of</strong> NBN founder mutation in Lviv population may contribute to<br />

cancer frequency in the West Ukraine.<br />

P10.65<br />

the spectrum <strong>of</strong> GJB2 (connexin-26) mutations in patients<br />

with nonsyndromic hearing loss: high prevalence <strong>of</strong> the allelic<br />

variant V37i (109G>A) in Asian populations <strong>of</strong> sakha (Yakutia)<br />

N. A. Barashkov 1 , L. U. Dzhemileva 2 , S. A. Fedorova 1 , F. M. Terutin 3 , E. E.<br />

Fedotova 3 , E. K. Khusnutdinova 2 ;<br />

1 Yakut Scientific Centre <strong>of</strong> Complex medical problems, Siberian Branch <strong>of</strong><br />

Russian Academy <strong>of</strong> Medical Sciences, Yakutsk, Russian Federation, 2 Institute<br />

<strong>of</strong> Biochemistry and <strong>Genetics</strong>, Ufa Research Centre, Russian Academy <strong>of</strong> Sciences,<br />

Ufa, Russian Federation, 3 Republican Hospital №1 – National Centre <strong>of</strong><br />

Medicine, Yakutsk, Russian Federation.<br />

Congenital hearing loss is one <strong>of</strong> the frequent sensory defects affecting<br />

1-3 in 1000 newborns, and 50% <strong>of</strong> these cases are hereditary determined.<br />

Nonsyndromic hearing loss (NSHL) accounts approximately<br />

80% <strong>of</strong> hereditary deafness cases. GJB2 mutations are implicated as a<br />

major cause for the development <strong>of</strong> NSHL in majority <strong>of</strong> populations.<br />

We studied GJB2 mutation spectrum in patients with NSHL in Sakha<br />

Republic (Yakutia) (East Siberia, Russia). A total <strong>of</strong> 66 patients with<br />

NSHL <strong>of</strong> different ethnic affiliation (Caucasians and Asians) were analyzed<br />

by PCR-SSCP and further sequencing <strong>of</strong> GJB2 gene. The molecular<br />

screening <strong>of</strong> V37I in 6 populations <strong>of</strong> Yakutia (Yakuts, Dolgans,<br />

Evenks, Evens, Yukaghirs and Russians) was performed using allelespecific<br />

amplification PCR method.<br />

GJB2 mutations were found in 50.0% <strong>of</strong> Caucasian and 9.2% <strong>of</strong> Asian<br />

patients chromosomes. We identified 3 different deletions 35delG,<br />

312del14, 333-334delAA known as recessive and 5 different missense<br />

mutations V27I, M34T, V37I, R127H, E114G which pathogenic role is<br />

controversial. One <strong>of</strong> the common allelic variants in Asian patients is<br />

V37I (45% <strong>of</strong> all mutant chromosomes). Molecular screening <strong>of</strong> V37I<br />

in 6 populations <strong>of</strong> Yakutia showed that it was one <strong>of</strong> the common<br />

allelic variant in studied populations. We found the V37I allele in Turkic-speaking<br />

populations <strong>of</strong> Yakuts, Tungusic-speaking populations <strong>of</strong><br />

Evenks and Evens and Slavic-speaking ones <strong>of</strong> Russians. V37I was<br />

not detected in populations <strong>of</strong> Dolgans and Yukaghirs. High prevalence<br />

<strong>of</strong> V37I in populations <strong>of</strong> Yakutia may be a result <strong>of</strong> common<br />

founder effect.<br />

This work was supported by RFBR (08-04-90730) and RHSF (08-06-<br />

84602a/U).<br />

P10.66<br />

the comparative analysis <strong>of</strong> hereditary skeletal disorders’<br />

spectrum in Rostov region<br />

R. A. Valkov 1 , S. S. Amelina 2 , R. A. Zinchenko 3 ;<br />

1 Railroad clinical hospital, Rostov-on-Don, Russian Federation, 2 Rostov regional<br />

clinical hospital, Rostov-on-Don, Russian Federation, 3 Research Centre<br />

for Medical <strong>Genetics</strong>, Russian Academy <strong>of</strong> Medical Sciences (RCMG RAMS),<br />

Moscow, Russian Federation.<br />

Hereditary skeletal disorders (HSD) are a large heterogeneous group<br />

<strong>of</strong> genetic diseases with different prevalence rate in populations. A<br />

cumulative international incidence <strong>of</strong> at least 1:5000 newborns has<br />

been estimated (in most cases, it was estimated by cumulating information<br />

from the different publications). The following ten syndromes:<br />

Marfan syndrome - 30:100,000; Arthrogryposis multiplex congenita<br />

- 30:100,000; Polydactyly, preaxial - 25:100,000; Syndactyly, type 1<br />

- 25:100,000; Ehlers-Danlos syndrome, type 3 - 12.5:100,000; Osteogenesis<br />

imperfecta - 6.5:100,000; Achondroplasia - 4.5:100,000;<br />

Epiphyseal dysplasia multiple - 5:100,000; Acrocephalosyndactyly<br />

- 4.6:100,000; Diastrophic dwarfism - 3.5:100,000 were the most<br />

frequent HSD (isolated and syndromic forms) in the world. 320925<br />

people <strong>of</strong> eight areas <strong>of</strong> Rostov region were examined. The research<br />

was made taken under the RCMG RAMS protocol, which, according<br />

to OMIM, provides more than 2500 genetic diseases diagnosis.<br />

Then families with HSD were selected from the cite data. In the results<br />

336 patients from 226 families were detected with HSD. The total<br />

prevalence rate <strong>of</strong> HSD in Rostov region was 1:950. The following ten<br />

syndromes: Ehlers-Danlos syndrome, type 3 - 15.6:100,000; Marfan<br />

syndrome - 5:100,000; scoliosis, idiopathic - 5:100,000; Polydactyly,<br />

postaxial - 4.7:100,000; Noonan syndrome - 4:100,000; Syndactyly,<br />

type 1 - 3.7:100,000; Osteogenesis imperfecta - 3.1:100,000; Achondroplasia<br />

- 2.8:100,000; Syndactyly, type 2 - 2.8:100,000; Polydactyly,<br />

preaxial - 2.5:100,000 were the most frequent HSD in the Rostov region.<br />

Diversity and incidence <strong>of</strong> the most frequent HSD differs from the<br />

world data. The further research will enable to reveal the reasons <strong>of</strong><br />

this regional HDS spread peculiarities.<br />

P10.67<br />

Epidemiological aspects <strong>of</strong> Osteogenesis imperfecta in<br />

Bashkortostan Republic <strong>of</strong> Russia<br />

D. Nadyrshina1 , R. Khusainova1 , A. Mardanova2 , E. Khusnutdinova1 ;<br />

1 2 Institute <strong>of</strong> Biochemistry and <strong>Genetics</strong> RAS, Ufa, Russian Federation, Republic<br />

Perinatal Centre, Ufa, Russian Federation.<br />

Osteogenesis imperfecta (OI) is a clinically and genetically heterogeneous<br />

disorder <strong>of</strong> connective tissue characterized by brittle bones, blue<br />

sclerae, short stature, bone deformity, hearing loss and dentinogenesis<br />

imperfecta. 95 patients with OI are identified from 90 families the<br />

Republic <strong>of</strong> Bashkortostan (RB). The prevalence <strong>of</strong> OI is estimated at<br />

1 per 45000, whereas in other countries <strong>of</strong> the world it is estimated to<br />

be 1:10000-1:30000. Our results show that OI is extended irregularly<br />

in the RB. The disease is detected in 29 from 54 administrative districts<br />

and in 12 from 21 cities. The incidence <strong>of</strong> OI varies from 0.42:100000<br />

to 17.8:100000. The distribution <strong>of</strong> patients by the sex composition<br />

is as follows 52males and 43 females. Epidemiological investigations<br />

based on the ethnic composition <strong>of</strong> 95 patients with OI scattered are<br />

as follows: Tatars -29.4%, Russians- 23.1%, Bashkirs - 18.9%, 6.2%<br />

from Armenians, Maris, Ukrainians, Chuvashes and 22.4% are metis.<br />

70 from 95 cases have blue sclera (34males and 36females). 16<br />

patients have autosomal dominant and 79 have autosomal recessive<br />

inheritance pattern. More than 10 fractures during their lifetime had 39<br />

patients, multiple fractures - 33 patients and 23 patients didn`t have<br />

fractures. The distribution <strong>of</strong> patients with OI by the age composition is<br />

congenital 22 cases (26%), from 1 to 7 years old 35 patients (42.8%)<br />

and from 8 and older 27 cases (32.3%). The irregular prevalence <strong>of</strong> OI<br />

in RB, apparently, occurs randomly as absence <strong>of</strong> patterns associated<br />

with local concentration incidents with OI.<br />

P10.68<br />

study <strong>of</strong> two common P53 gene mutations in gastric cancer<br />

using (PcR-RFLP) in a Province <strong>of</strong> iran<br />

J. Saffari Chaleshtori 1 , M. Moradi 2 , E. Farrokhi 2 , M. Tabatabaieefar 2 , M. Taherzadeh<br />

Ghahfarrokhi 1 , G. Mobini 2 , S. Khademi 2 , F. Shayesteh 2 , M. Shahrani 2 , G.<br />

Mardani 2 , M. Banitalebi 2 , N. Parvin 2 , N. Shahinfar 2 , G. Rahimian 2 , H. Nazem 3 ,<br />

M. Hashemzadeh Chaleshtori 2 ;<br />

1 Payame Noor Univ. Tehran & Cellular and Molecular Research Center<br />

Shahrekord Univ. <strong>of</strong> Med.Sci. Iran, Shahrekord, Islamic Republic <strong>of</strong> Iran,<br />

2 Cellular and Molecular Research Center Shahrekord Univ. <strong>of</strong> Med.Sci. Iran,<br />

Shahrekord, Islamic Republic <strong>of</strong> Iran, 3 Payame Noor Univ. Tehran, Shahrekord,<br />

Islamic Republic <strong>of</strong> Iran.<br />

Background and aim: Gastric cancer is the most common cause <strong>of</strong><br />

cancer death world wide after lung cancer. Genetic factors including<br />

oncogenes and tumor suppressor genes are always involved in progression<br />

<strong>of</strong> this cancer. The P53 tumor suppressor gene is believed<br />

to have a broad role in the cell such as programmed cell death and<br />

stop cell replicating damaged DNA which has been summarized on the<br />

guardian <strong>of</strong> the genome. This study aims to determine the frequency <strong>of</strong><br />

two common P53 gene mutations using PCR-RFLP in gastric cancer<br />

in a Province <strong>of</strong> Iran

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!